Market Tracker

12/12 5:15pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.59
Delayed Data
As of 3:57pm ET
 +0.0055 / +0.94%
Today’s Change
0.43
Today|||52-Week Range
1.50
-52.03%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.58
Today’s open0.58
Day’s range0.58 - 0.63
Volume238,527
Average volume (3 months)489,409
Market cap$22.6M
Data as of 3:57pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-15.15%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-4.30%
P/E ratioNM
Price/Sales2.91
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
SNOASonoma Pharmaceutica...-0.15-3.22%
----
CAPRCapricor Therapeutic...-0.10-5.88%
DFFNDiffusion Pharmaceut...0.000.00%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$8.9M
Annual profit (last year)-$29.4M
Net profit margin-330.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts